Midatech: Eyes best day in 17 months on joint research into drug delivery platform
21/07/2020 17:04
** U.S.-listed shares of drug developer MTP.O more than
triple to $5.62; set for their best day since Feb. 26, 2019
** Stock top pct gainer across U.S. exchanges
** Co says it has entered into a research collaboration with
a European affiliate of a global pharma co for its drug delivery
platform, Q-Sphera urn:newsml:reuters.com:*:nRSU6125Ta
** Q-Sphera is a micro-tech for sustained release of drug,
and can prolong and control the release of therapeutics over an
extended period of time
** If the study is successful, the pharma company will be
required to enter into a licence agreement to use the Q-Sphera
platform - MTP
** Stock up 63.4% so far this year
(Reporting by Dania Nadeem in Bengaluru)
((Dania.Nadeem@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3463;))